Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.
about
Epigenetics of Alzheimer's disease and frontotemporal dementiaDisrupting the networks of cancerEndoplasmic reticulum stress plays a pivotal role in cell death mediated by the pan-deacetylase inhibitor panobinostat in human hepatocellular cancer cells.Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells.Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell linesSuberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction networkOverview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transitionRegulators of gene expression as biomarkers for prostate cancerREST is a novel prognostic factor and therapeutic target for medulloblastomaRole of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid MalignanciesHistone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.Histone Deacetylase Inhibitors as Anticancer Drugs.Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.Combination of bendamustine and entinostat synergistically inhibits proliferation of multiple myeloma cells via induction of apoptosis and DNA damage response.Histone de-acetylase inhibitors: a promising future for cancer treatment?The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma modelsEpigenetic therapies - a new direction in clinical medicine.Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
P2860
Q27010153-1D8E4706-C3BD-4162-A409-AC4F330ACA3BQ28656016-8110BBC9-E8BF-4AF0-8786-6D2246EC6726Q30455973-E03AE80E-39BC-48C7-A3E9-091920E60BCFQ30541284-8D28175D-E27B-48BA-99B8-EB1F5C103F1FQ33750712-4842F9C2-E06B-4C5B-A96D-63B467112697Q34468386-EAE41438-1F32-4194-980E-7C0C2C4711AEQ34788381-DB329391-6D36-4EAA-B989-349A6837F950Q36184617-788AC96E-6268-48A8-ACFD-14DEE1BD6431Q36282754-DAE56208-482D-41D9-BEA2-A252D573D21CQ36288249-B07AF503-B5CF-491E-AEDB-A0FA5184033AQ36356117-EDEC1A5B-B3A3-4BFD-80D4-BA29FA6DFB1AQ36439912-6706A736-286D-4F78-87BA-61D01D0FBD0FQ37148990-715FF0F7-9DFE-4E1C-AE0E-84931F1D58DEQ37226511-36C3EADF-500F-4DA8-BE10-DB7BB6A24BC1Q37399295-912E8DDB-196F-4679-BBD7-DBD71EB855D5Q38696932-3BC3E982-04A1-4541-A5FE-01A8F1C8A905Q39009379-380A49E5-5C18-4AC4-AD91-AF7368B82816Q39185574-D1637A44-A253-48DF-B777-2367B78681BAQ39450752-E6ED75AD-03DA-4CD4-8B44-BF921C656DBFQ42164554-49F6F1B8-5E2C-4296-8A65-820AAF80ED0FQ51733858-D5C619F7-EE85-4873-AE20-B760DFF6030CQ55110970-9A666C73-7BC3-4F0B-B287-1F26F7BBD2EFQ58792448-8F9E0753-0300-4B56-BD05-9C9C906744AA
P2860
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@en
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@nl
type
label
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@en
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@nl
prefLabel
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@en
Therapeutic strategies to enha ...... istone deacetylase inhibitors.
@nl
P2093
P2860
P356
P1476
Therapeutic strategies to enha ...... histone deacetylase inhibitors
@en
P2093
Claudia P Miller
Joya Chandra
Melissa M Singh
Nilsa Rivera-Del Valle
P2860
P304
P356
10.1155/2011/514261
P577
2011-06-28T00:00:00Z